CD4 and periodontitis: In summary, our findings demonstrate that RATEVs suppress CD4+ T‐cell‐mediated inflammatory and osteolytic responses and ameliorate alveolar bone loss in experimental periodontitis, likely through mechanisms involving the CD73/ADO signalling pathway.